⌘K

Login Start Free

Home/Filings/4/0001181431-12-065666

4//SEC Filing

Singhvi Rahul 4

Accession 0001181431-12-065666

CIK 0000822411other

View on SEC.gov Company Profile

Filed

Dec 17, 7:00 PM ET

Accepted

Dec 18, 5:33 PM ET

Size

5.3 KB

Accession

0001181431-12-065666

Insider Transaction Report

Form 4

Period: 2012-09-24

ImmunoCellular Therapeutics, Ltd.IMUC

Director

Transactions

Award
Stock Option (right to buy)
2012-09-24+75,000→ 75,000 total
Exercise: $3.00Exp: 2019-09-23→ Common Stock (75,000 underlying)

Footnotes (1)

[F1]The option vests in equal quarterly installments for four years following September 24, 2012.

Documents

1 file

4
rrd363840.xmlPrimary
PRIMARY DOCUMENT

Issuer

ImmunoCellular Therapeutics, Ltd.

CIK 0000822411

Entity typeother

Related Parties

1

filerCIK 0001322731

Filing Metadata

Form type: 4
Filed: Dec 17, 7:00 PM ET
Accepted: Dec 18, 5:33 PM ET
Size: 5.3 KB

View on SEC.gov